
Nerve Repair and Regeneration Market Size and Share - Outlook Report, Forecast Trends and Growth Analysis (2025-2034)
Description
The global nerve repair and regeneration market attained a value of USD 9.33 Billion in 2024 driven by the rising prevalence of neurodegenerative disorders with technological advancements across the globe. It is expected to grow at a CAGR of 15.10% in the forecast period of 2025-2034 and attain a value of USD 38.07 Billion by 2034.
Nerve Repair and Regeneration Market Overview
Neural repair and regeneration help in healing and restoring damaged nerves in the brain and spinal cord. They work with different types of nerve injuries related to trauma, neurodegenerative disorders, and specific surgeries. These injuries may affect the quality of life of a person adversely, often resulting in paralysis or loss of sensation. The market is witnessing an increased integration of technical advancements to bring improved solutions to patients. Preference for minimally invasive procedures, focus on personalised treatments and expanding use of stem cell therapies are amongst the major market trends.
Nerve Repair and Regeneration Market Growth Drivers
Increasing Prevalence of Neurodegenerative Disorders Boosts Market Growth
One of the most significant factors contributing to the market growth for nerve repair is the growing cases of nerve disorders and damage. According to the World Health Organization, Parkinson’s disease affects approximately more than 10 million people all over the world while Alzheimer’s disease affects 55 million people. With the increasing incidence of these diseases, there is a high demand for better and improved treatments. Hence, the need for products like nerve grafts, nerve conduits, and other products that aid in the healing and care of affected nerves is on the rise.
Surge in Research Initiatives and Product Launches to Meet Rising Nerve Repair and Regeneration Market Demand
Researchers are developing new products such as nerve conduits that assist in nerve regrowth. Such technological advancements are aimed at helping many patients regain their nerve function. In May 2024, researchers at the University of Birmingham created a red light therapy for enhancing nerve growth and function to repair spinal cord injuries. With the use of 660nm light, the treatment decreased scarring and revived feeling and mobility in preclinical models.
Moreover, the launch of new products that offer advanced products to the users are expected to fuel market growth in the coming years. For instance, In June 2024, Axogen, Inc. introduced Avive+ Soft Tissue Matrix, a novel product created for safeguarding soft tissue during the recovery of peripheral nerves. The resorbable amniotic membrane allograft acts as a temporary barrier to aid in the healing process of nerve injuries such as carpal and cubital tunnel syndromes. Avive+ complies with FDA guidelines for tissue products, broadening Axogen’s range of nerve protection solutions.
Nerve Repair and Regeneration Market Trends
Use of Minimally Invasive Procedures
Doctors are increasingly using less invasive procedures, so as to reduce patient pain and shorten hospital stays. The trend for minimally invasive procedures is expected to continue as people tend to choose lower-risk and less painful treatments.
Rising Use of Biomaterials to Boost the Nerve Repair and Regeneration Market Value
Biomaterials are more commonly used to promote tissue healing and address nerve regeneration. They provide support for the regeneration of nerves that have been damaged and further enhancements in the application of biomaterials is expected to elevate the market size significantly in the forecast period.
Growing Use of Stem Cell Therapies
Stem cell therapies are growing in usage for nerve regeneration with more tests being conducted. These therapies assist in replacing injured neurons and are expected to have larger application prospects in the forecast period.
Focus on Personalized Treatments
A significant trend in the market involves developing customized therapies for repairing nerves, with doctors tailoring treatments to match an individual's specific biology. Personalised treatments are expected to become increasingly popular as improvements in medical technology enable more personalized approaches.
Nerve Repair and Regeneration Market Segmentation
Market Breakup by Product
Market Segmentation Based on End User Set to Witness Substantial Growth
Based on end users, the market is divided into hospitals, specialized clinics, research and academic institutes, and others. Among these, hospitals are expected to dominate the market due to their well-developed infrastructure and well-trained healthcare professionals to deal with complicated operational procedures.
Nerve Repair and Regeneration Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is expected to dominate the market due to the high incidence of neurodegenerative disorders, an existing and developed network of healthcare providers, and increased concern for R&D. The market share can also be attributed to suitable reimbursement policies in this region.
On the other hand, the Asia Pacific is expected to become another prominent market for nerve repair and regeneration due to growing concerns around the healthcare budget, the increasing incidence of neurological disorders, and the growing availability of innovative treatment options in the region.
Leading Players in the Nerve Repair and Regeneration Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Medtronic plc
Medtronic plc was founded in 1949 and is based in Dublin. It is one of the largest medical device companies in the world. Medtronic also produces neurostimulation devices that utilize electrical impulses to promote nerve healing and can be employed in managing chronic pain and nerve damage.
AxoGen, Inc.
Based in Alachua, Florida, and was established in 2002. The primary focus is on products intended for repairing nerve damage, such as nerve conduits and nerve shields. AxoGen has made a name for itself as a pioneer in addressing peripheral nerve injuries.
Stryker Corporation
Stryker Corporation, founded in 1941, is headquartered in Kalamazoo, Michigan. It produces instruments and equipment used in nerve surgeries such as neurosurgery and neurovascular instruments. Nerve repair is among the most critical areas that utilize Stryker’s products, making it a vital market player.
Boston Scientific Corporation
Founded in 1979 and headquartered in Marlborough, Massachusetts, the company specializes in the production of medical devices. It provides neurostimulation products for treating Chronic Intractable Pain and promoting nerve regrowth. These devices are employed for pain and taken to the functional level for patients with severe nerve injuries.
Other companies include Nerve Repair and Regeneration, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Collagen Matrix Inc., Medovex Corporation, and Axogen Corporation.
Key Questions Answered in the Nerve Repair and Regeneration Market
Nerve Repair and Regeneration Market Overview
Neural repair and regeneration help in healing and restoring damaged nerves in the brain and spinal cord. They work with different types of nerve injuries related to trauma, neurodegenerative disorders, and specific surgeries. These injuries may affect the quality of life of a person adversely, often resulting in paralysis or loss of sensation. The market is witnessing an increased integration of technical advancements to bring improved solutions to patients. Preference for minimally invasive procedures, focus on personalised treatments and expanding use of stem cell therapies are amongst the major market trends.
Nerve Repair and Regeneration Market Growth Drivers
Increasing Prevalence of Neurodegenerative Disorders Boosts Market Growth
One of the most significant factors contributing to the market growth for nerve repair is the growing cases of nerve disorders and damage. According to the World Health Organization, Parkinson’s disease affects approximately more than 10 million people all over the world while Alzheimer’s disease affects 55 million people. With the increasing incidence of these diseases, there is a high demand for better and improved treatments. Hence, the need for products like nerve grafts, nerve conduits, and other products that aid in the healing and care of affected nerves is on the rise.
Surge in Research Initiatives and Product Launches to Meet Rising Nerve Repair and Regeneration Market Demand
Researchers are developing new products such as nerve conduits that assist in nerve regrowth. Such technological advancements are aimed at helping many patients regain their nerve function. In May 2024, researchers at the University of Birmingham created a red light therapy for enhancing nerve growth and function to repair spinal cord injuries. With the use of 660nm light, the treatment decreased scarring and revived feeling and mobility in preclinical models.
Moreover, the launch of new products that offer advanced products to the users are expected to fuel market growth in the coming years. For instance, In June 2024, Axogen, Inc. introduced Avive+ Soft Tissue Matrix, a novel product created for safeguarding soft tissue during the recovery of peripheral nerves. The resorbable amniotic membrane allograft acts as a temporary barrier to aid in the healing process of nerve injuries such as carpal and cubital tunnel syndromes. Avive+ complies with FDA guidelines for tissue products, broadening Axogen’s range of nerve protection solutions.
Nerve Repair and Regeneration Market Trends
Use of Minimally Invasive Procedures
Doctors are increasingly using less invasive procedures, so as to reduce patient pain and shorten hospital stays. The trend for minimally invasive procedures is expected to continue as people tend to choose lower-risk and less painful treatments.
Rising Use of Biomaterials to Boost the Nerve Repair and Regeneration Market Value
Biomaterials are more commonly used to promote tissue healing and address nerve regeneration. They provide support for the regeneration of nerves that have been damaged and further enhancements in the application of biomaterials is expected to elevate the market size significantly in the forecast period.
Growing Use of Stem Cell Therapies
Stem cell therapies are growing in usage for nerve regeneration with more tests being conducted. These therapies assist in replacing injured neurons and are expected to have larger application prospects in the forecast period.
Focus on Personalized Treatments
A significant trend in the market involves developing customized therapies for repairing nerves, with doctors tailoring treatments to match an individual's specific biology. Personalised treatments are expected to become increasingly popular as improvements in medical technology enable more personalized approaches.
Nerve Repair and Regeneration Market Segmentation
Market Breakup by Product
- Neurostimulation and Neuromodulation Devices
- Internal Neurostimulation Device
- Spinal Cord Stimulation
- Deep Brain Stimulation
- Vagus Nerve Stimulation
- Sacral Nerve Stimulation
- Gastric Electrical Stimulation
- External Neurostimulation Device
- Transcutaneous Electrical Nerve Stimulation
- Transcranial Magnetic Stimulation
- Biomaterials
- Nerve Conduit
- Nerve Protector
- Nerve Connector
- Others
- Stem Cell Therapy
- Gene Therapy
- 3D Bioprinting
- Electrotherapy
- Neurostimulation and Neuromodulation Surgeries
- Direct Nerve Repair
- Nerve Grafting
- Stem Cell Therapy
- Others
- Hospitals
- Specialized Clinics
- Research and Academic Institutes
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Market Segmentation Based on End User Set to Witness Substantial Growth
Based on end users, the market is divided into hospitals, specialized clinics, research and academic institutes, and others. Among these, hospitals are expected to dominate the market due to their well-developed infrastructure and well-trained healthcare professionals to deal with complicated operational procedures.
Nerve Repair and Regeneration Market Analysis by Region
Regionally, the market report offers an insight into North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is expected to dominate the market due to the high incidence of neurodegenerative disorders, an existing and developed network of healthcare providers, and increased concern for R&D. The market share can also be attributed to suitable reimbursement policies in this region.
On the other hand, the Asia Pacific is expected to become another prominent market for nerve repair and regeneration due to growing concerns around the healthcare budget, the increasing incidence of neurological disorders, and the growing availability of innovative treatment options in the region.
Leading Players in the Nerve Repair and Regeneration Market
The key features of the market report include patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Medtronic plc
Medtronic plc was founded in 1949 and is based in Dublin. It is one of the largest medical device companies in the world. Medtronic also produces neurostimulation devices that utilize electrical impulses to promote nerve healing and can be employed in managing chronic pain and nerve damage.
AxoGen, Inc.
Based in Alachua, Florida, and was established in 2002. The primary focus is on products intended for repairing nerve damage, such as nerve conduits and nerve shields. AxoGen has made a name for itself as a pioneer in addressing peripheral nerve injuries.
Stryker Corporation
Stryker Corporation, founded in 1941, is headquartered in Kalamazoo, Michigan. It produces instruments and equipment used in nerve surgeries such as neurosurgery and neurovascular instruments. Nerve repair is among the most critical areas that utilize Stryker’s products, making it a vital market player.
Boston Scientific Corporation
Founded in 1979 and headquartered in Marlborough, Massachusetts, the company specializes in the production of medical devices. It provides neurostimulation products for treating Chronic Intractable Pain and promoting nerve regrowth. These devices are employed for pain and taken to the functional level for patients with severe nerve injuries.
Other companies include Nerve Repair and Regeneration, Zimmer Biomet Holdings, Inc., Integra LifeSciences Holdings Corporation, Collagen Matrix Inc., Medovex Corporation, and Axogen Corporation.
Key Questions Answered in the Nerve Repair and Regeneration Market
- What was the global nerve repair and regeneration market value in 2024?
- What is the global nerve repair and regeneration market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on the product?
- What is the market breakup based on technology?
- What is the market segmentation based on the application?
- What is the market breakup based on the end user?
- What are the major factors aiding the global nerve repair and regeneration market demand?
- What are the market's major drivers, opportunities, and restraints?
- Which regional market is expected to lead the market share in the forecast period?
- Which country is expected to experience expedited growth during the forecast period?
- What are the major global nerve repair and regeneration market trends?
- How does the rise in the geriatric population impact the market size?
- Who are the key players involved in the nerve repair and regeneration market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
- What role does 3D bioprinting play in the future of nerve regeneration technologies?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Nerve Repair and Regeneration Market Overview
- 3.1 Global Nerve Repair and Regeneration Market Historical Value (2018-2024)
- 3.2 Global Nerve Repair and Regeneration Market Forecast Value (2025-2034)
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Nerve Repair and Regeneration Market Landscape*
- 5.1 Global Nerve Repair and Regeneration: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Nerve Repair and Regeneration: Product Landscape
- 5.2.1 Analysis by Product
- 5.2.2 Analysis by Modality
- 6 Global Nerve Repair and Regeneration Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Nerve Repair and Regeneration Market Segmentation (218-2034)
- 7.1 Global Nerve Repair and Regeneration Market (2018-2034) by Product
- 7.1.1 Market Overview
- 7.1.2 Neurostimulation and Neuromodulation Devices
- 7.1.3 Internal Neurostimulation Device
- 7.1.3.1 Spinal Cord Stimulation
- 7.1.3.2 Deep Brain Stimulation
- 7.1.3.3 Vagus Nerve Stimulation
- 7.1.3.4 Sacral Nerve Stimulation
- 7.1.3.5 Gastric Electrical Stimulation
- 7.1.4 External Neurostimulation Device
- 7.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 7.1.4.2 Transcranial Magnetic Stimulation
- 7.1.5 Biomaterials
- 7.1.5.1 Nerve Conduit
- 7.1.5.2 Nerve Protector
- 7.1.5.3 Nerve Connector
- 7.1.5.4 Others
- 7.2 Global Nerve Repair and Regeneration Market (2018-2034) by Technology
- 7.2.1 Market Overview
- 7.2.2 Stem Cell Therapy
- 7.2.3 Gene Therapy
- 7.2.4 3D Bioprinting
- 7.2.5 Electrotherapy
- 7.3 Global Nerve Repair and Regeneration Market (2018-2034) by Application
- 7.3.1 Market Overview
- 7.3.2 Neurostimulation and Neuromodulation Surgeries
- 7.3.3 Direct Nerve Repair
- 7.3.4 Nerve Grafting
- 7.3.5 Stem Cell Therapy
- 7.3.6 Others
- 7.4 Global Nerve Repair and Regeneration Market (2018-2034) by End User
- 7.4.1 Market Overview
- 7.4.2 Hospitals
- 7.4.3 Specialized Clinics
- 7.4.4 Research and Academic Institutes
- 7.4.5 Others
- 7.5 Global Nerve Repair and Regeneration Market (2018-2034) by Region
- 7.5.1 Market Overview
- 7.5.2 North America
- 7.5.3 Europe
- 7.5.4 Asia Pacific
- 7.5.5 Latin America
- 7.5.6 Middle East and Africa
- 8 North America Nerve Repair and Regeneration Market (218-2034)
- 8.1 North America Nerve Repair and Regeneration Market (2018-2034) by Product
- 8.1.1 Market Overview
- 8.1.2 Neurostimulation and Neuromodulation Devices
- 8.1.3 Internal Neurostimulation Device
- 8.1.3.1 Spinal Cord Stimulation
- 8.1.3.2 Deep Brain Stimulation
- 8.1.3.3 Vagus Nerve Stimulation
- 8.1.3.4 Sacral Nerve Stimulation
- 8.1.3.5 Gastric Electrical Stimulation
- 8.1.4 External Neurostimulation Device
- 8.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 8.1.4.2 Transcranial Magnetic Stimulation
- 8.1.5 Biomaterials
- 8.1.5.1 Nerve Conduit
- 8.1.5.2 Nerve Protector
- 8.1.5.3 Nerve Connector
- 8.1.5.4 Others
- 8.2 North America Nerve Repair and Regeneration Market (2018-2034) by Technology
- 8.2.1 Market Overview
- 8.2.2 Stem Cell Therapy
- 8.2.3 Gene Therapy
- 8.2.4 3D Bioprinting
- 8.2.5 Electrotherapy
- 8.3 North America Nerve Repair and Regeneration Market (2018-2034) by Application
- 8.3.1 Market Overview
- 8.3.2 Neurostimulation and Neuromodulation Surgeries
- 8.3.3 Direct Nerve Repair
- 8.3.4 Nerve Grafting
- 8.3.5 Stem Cell Therapy
- 8.3.6 Others
- 8.4 North America Nerve Repair and Regeneration Market (2018-2034) by End User
- 8.4.1 Market Overview
- 8.4.2 Hospitals
- 8.4.3 Specialized Clinics
- 8.4.4 Research and Academic Institutes
- 8.4.5 Others
- 8.5 North America Nerve Repair and Regeneration Market (2018-2034) by Country
- 8.5.1 United States of America
- 8.5.2 Canada
- 9 Europe Nerve Repair and Regeneration Market (218-2034)
- 9.1 Europe Nerve Repair and Regeneration Market (2018-2034) by Product
- 9.1.1 Market Overview
- 9.1.2 Neurostimulation and Neuromodulation Devices
- 9.1.3 Internal Neurostimulation Device
- 9.1.3.1 Spinal Cord Stimulation
- 9.1.3.2 Deep Brain Stimulation
- 9.1.3.3 Vagus Nerve Stimulation
- 9.1.3.4 Sacral Nerve Stimulation
- 9.1.3.5 Gastric Electrical Stimulation
- 9.1.4 External Neurostimulation Device
- 9.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 9.1.4.2 Transcranial Magnetic Stimulation
- 9.1.5 Biomaterials
- 9.1.5.1 Nerve Conduit
- 9.1.5.2 Nerve Protector
- 9.1.5.3 Nerve Connector
- 9.1.5.4 Others
- 9.2 Europe Nerve Repair and Regeneration Market (2018-2034) by Technology
- 9.2.1 Market Overview
- 9.2.2 Stem Cell Therapy
- 9.2.3 Gene Therapy
- 9.2.4 3D Bioprinting
- 9.2.5 Electrotherapy
- 9.3 Europe Nerve Repair and Regeneration Market (2018-2034) by Application
- 9.3.1 Market Overview
- 9.3.2 Neurostimulation and Neuromodulation Surgeries
- 9.3.3 Direct Nerve Repair
- 9.3.4 Nerve Grafting
- 9.3.5 Stem Cell Therapy
- 9.3.6 Others
- 9.4 Europe Nerve Repair and Regeneration Market (2018-2034) by End User
- 9.4.1 Market Overview
- 9.4.2 Hospitals
- 9.4.3 Specialized Clinics
- 9.4.4 Research and Academic Institutes
- 9.4.5 Others
- 9.5 Europe Nerve Repair and Regeneration Market (2018-2034) by Country
- 9.5.1 United Kingdom
- 9.5.2 Germany
- 9.5.3 France
- 9.5.4 Italy
- 9.5.5 Others
- 10 Asia Pacific Nerve Repair and Regeneration Market (218-2034)
- 10.1 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Product
- 10.1.1 Market Overview
- 10.1.2 Neurostimulation and Neuromodulation Devices
- 10.1.3 Internal Neurostimulation Device
- 10.1.3.1 Spinal Cord Stimulation
- 10.1.3.2 Deep Brain Stimulation
- 10.1.3.3 Vagus Nerve Stimulation
- 10.1.3.4 Sacral Nerve Stimulation
- 10.1.3.5 Gastric Electrical Stimulation
- 10.1.4 External Neurostimulation Device
- 10.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 10.1.4.2 Transcranial Magnetic Stimulation
- 10.1.5 Biomaterials
- 10.1.5.1 Nerve Conduit
- 10.1.5.2 Nerve Protector
- 10.1.5.3 Nerve Connector
- 10.1.5.4 Others
- 10.2 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Technology
- 10.2.1 Market Overview
- 10.2.2 Stem Cell Therapy
- 10.2.3 Gene Therapy
- 10.2.4 3D Bioprinting
- 10.2.5 Electrotherapy
- 10.3 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Application
- 10.3.1 Market Overview
- 10.3.2 Neurostimulation and Neuromodulation Surgeries
- 10.3.3 Direct Nerve Repair
- 10.3.4 Nerve Grafting
- 10.3.5 Stem Cell Therapy
- 10.3.6 Others
- 10.4 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by End User
- 10.4.1 Market Overview
- 10.4.2 Hospitals
- 10.4.3 Specialized Clinics
- 10.4.4 Research and Academic Institutes
- 10.4.5 Others
- 10.5 Asia Pacific Nerve Repair and Regeneration Market (2018-2034) by Country
- 10.5.1 China
- 10.5.2 Japan
- 10.5.3 India
- 10.5.4 ASEAN
- 10.5.5 Australia
- 10.5.6 Others
- 11 Latin America Nerve Repair and Regeneration Market (218-2034)
- 11.1 Latin America Nerve Repair and Regeneration Market (2018-2034) by Product
- 11.1.1 Market Overview
- 11.1.2 Neurostimulation and Neuromodulation Devices
- 11.1.3 Internal Neurostimulation Device
- 11.1.3.1 Spinal Cord Stimulation
- 11.1.3.2 Deep Brain Stimulation
- 11.1.3.3 Vagus Nerve Stimulation
- 11.1.3.4 Sacral Nerve Stimulation
- 11.1.3.5 Gastric Electrical Stimulation
- 11.1.4 External Neurostimulation Device
- 11.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 11.1.4.2 Transcranial Magnetic Stimulation
- 11.1.5 Biomaterials
- 11.1.5.1 Nerve Conduit
- 11.1.5.2 Nerve Protector
- 11.1.5.3 Nerve Connector
- 11.1.5.4 Others
- 11.2 Latin America Nerve Repair and Regeneration Market (2018-2034) by Technology
- 11.2.1 Market Overview
- 11.2.2 Stem Cell Therapy
- 11.2.3 Gene Therapy
- 11.2.4 3D Bioprinting
- 11.2.5 Electrotherapy
- 11.3 Latin America Nerve Repair and Regeneration Market (2018-2034) by Application
- 11.3.1 Market Overview
- 11.3.2 Neurostimulation and Neuromodulation Surgeries
- 11.3.3 Direct Nerve Repair
- 11.3.4 Nerve Grafting
- 11.3.5 Stem Cell Therapy
- 11.3.6 Others
- 11.4 Latin America Nerve Repair and Regeneration Market (2018-2034) by End User
- 11.4.1 Market Overview
- 11.4.2 Hospitals
- 11.4.3 Specialized Clinics
- 11.4.4 Research and Academic Institutes
- 11.4.5 Others
- 11.5 Latin America Nerve Repair and Regeneration Market (2018-2034) by Country
- 11.5.1 Brazil
- 11.5.2 Argentina
- 11.5.3 Mexico
- 11.5.4 Others
- 12 Middle East and Africa Nerve Repair and Regeneration Market (218-2034)
- 12.1 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Product
- 12.1.1 Market Overview
- 12.1.2 Neurostimulation and Neuromodulation Devices
- 12.1.3 Internal Neurostimulation Device
- 12.1.3.1 Spinal Cord Stimulation
- 12.1.3.2 Deep Brain Stimulation
- 12.1.3.3 Vagus Nerve Stimulation
- 12.1.3.4 Sacral Nerve Stimulation
- 12.1.3.5 Gastric Electrical Stimulation
- 12.1.4 External Neurostimulation Device
- 12.1.4.1 Transcutaneous Electrical Nerve Stimulation
- 12.1.4.2 Transcranial Magnetic Stimulation
- 12.1.5 Biomaterials
- 12.1.5.1 Nerve Conduit
- 12.1.5.2 Nerve Protector
- 12.1.5.3 Nerve Connector
- 12.1.5.4 Others
- 12.2 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Technology
- 12.2.1 Market Overview
- 12.2.2 Stem Cell Therapy
- 12.2.3 Gene Therapy
- 12.2.4 3D Bioprinting
- 12.2.5 Electrotherapy
- 12.3 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Application
- 12.3.1 Market Overview
- 12.3.2 Neurostimulation and Neuromodulation Surgeries
- 12.3.3 Direct Nerve Repair
- 12.3.4 Nerve Grafting
- 12.3.5 Stem Cell Therapy
- 12.3.6 Others
- 12.4 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by End User
- 12.4.1 Market Overview
- 12.4.2 Hospitals
- 12.4.3 Specialized Clinics
- 12.4.4 Research and Academic Institutes
- 12.4.5 Others
- 12.5 Middle East and Africa Nerve Repair and Regeneration Market (2018-2034) by Country
- 12.5.1 Saudi Arabia
- 12.5.2 United Arab Emirates
- 12.5.3 Nigeria
- 12.5.4 South Africa
- 12.5.5 Others
- 13 Regulatory Framework
- 13.1 Regulatory Overview
- 13.2 US FDA
- 13.3 EU EMA
- 13.4 INDIA CDSCO
- 13.5 JAPAN PMDA
- 13.6 Others
- 14 Patent Analysis
- 14.1 Analysis by Type of Patent
- 14.2 Analysis by Publication Year
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Patent Age
- 14.5 Analysis by CPC Analysis
- 14.6 Analysis by Patent Valuation
- 14.7 Analysis by Key Players
- 15 Grants Analysis
- 15.1 Analysis by Year
- 15.2 Analysis by Amount Awarded
- 15.3 Analysis by Issuing Authority
- 15.4 Analysis by Grant Application
- 15.5 Analysis by Funding Institute
- 15.6 Analysis by NIH Departments
- 15.7 Analysis by Recipient Organization
- 16 Funding and Investment Analysis
- 16.1 Analysis by Funding Instances
- 16.2 Analysis by Type of Funding
- 16.3 Analysis by Funding Amount
- 16.4 Analysis by Leading Players
- 16.5 Analysis by Leading Investors
- 16.6 Analysis by Geography
- 17 Strategic Initiatives
- 17.1 Analysis by Partnership Instances
- 17.2 Analysis by Type of Partnership and Collaborations
- 17.3 Analysis by Joint Ventures
- 17.4 Analysis by Leading Players
- 17.5 Analysis by Geography
- 18 Supplier Landscape
- 18.1 Market Share Analysis, By Region (Top 5 Companies)
- 18.1.1 Market Share Analysis: Global
- 18.1.2 Market Share Analysis: North America
- 18.1.3 Market Share Analysis: Europe
- 18.1.4 Market Share Analysis: Asia Pacific
- 18.1.5 Market Share Analysis: Others
- 18.2 Medtronic plc
- 18.2.1 Financial Analysis
- 18.2.2 Product Portfolio
- 18.2.3 Demographic Reach and Achievements
- 18.2.4 Company News and Development
- 18.2.5 Certifications
- 18.3 AxoGen, Inc.
- 18.3.1 Financial Analysis
- 18.3.2 Product Portfolio
- 18.3.3 Demographic Reach and Achievements
- 18.3.4 Company News and Development
- 18.3.5 Certifications
- 18.4 Stryker Corporation
- 18.4.1 Financial Analysis
- 18.4.2 Product Portfolio
- 18.4.3 Demographic Reach and Achievements
- 18.4.4 Company News and Development
- 18.4.5 Certifications
- 18.5 Boston Scientific Corporation
- 18.5.1 Financial Analysis
- 18.5.2 Product Portfolio
- 18.5.3 Demographic Reach and Achievements
- 18.5.4 Company News and Development
- 18.5.5 Certifications
- 18.6 Nerve Repair and Regeneration
- 18.6.1 Financial Analysis
- 18.6.2 Product Portfolio
- 18.6.3 Demographic Reach and Achievements
- 18.6.4 Company News and Development
- 18.6.5 Certifications
- 18.7 Zimmer Biomet Holdings, Inc.
- 18.7.1 Financial Analysis
- 18.7.2 Product Portfolio
- 18.7.3 Demographic Reach and Achievements
- 18.7.4 Company News and Development
- 18.7.5 Certifications
- 18.8 Integra LifeSciences Holdings Corporation
- 18.8.1 Financial Analysis
- 18.8.2 Product Portfolio
- 18.8.3 Demographic Reach and Achievements
- 18.8.4 Company News and Development
- 18.8.5 Certifications
- 18.9 Collagen Matrix Inc.
- 18.9.1 Financial Analysis
- 18.9.2 Product Portfolio
- 18.9.3 Demographic Reach and Achievements
- 18.9.4 Company News and Development
- 18.9.5 Certifications
- 18.10 Medovex Corporation
- 18.10.1 Financial Analysis
- 18.10.2 Product Portfolio
- 18.10.3 Demographic Reach and Achievements
- 18.10.4 Company News and Development
- 18.10.5 Certifications
- 18.11 Axogen Corporation
- 18.11.1 Financial Analysis
- 18.11.2 Product Portfolio
- 18.11.3 Demographic Reach and Achievements
- 18.11.4 Company News and Development
- 18.11.5 Certifications
- 19 Global Nerve Repair and Regeneration Market – Distribution Model (Additional Insight)
- 19.1 Overview
- 19.2 Potential Distributors
- 19.3 Key Parameters for Distribution Partner Assessment
- 20 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.